Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Re-Named Melinta Moving Ahead With Delafloxacin And Novel Class Of Antibiotics

Oct 07 2013

Related Content

Rib-X Teams With Sanofi To Develop Novel, Broad-Spectrum Antibiotics

Jul 06 2011

Rib-X Counting On Rational Drug Design To Outsmart Resistant Bacteria

Oct 01 2011

Without an IPO, Rib-X Raises $67.5 Million In Venture Funding

Nov 29 2012

Related Companies

Melinta Therapeutics, Inc.

Pearl Therapeutics, Inc.

Yale University

AstraZeneca PLC

Sanofi

Pfizer Inc.

Additional Topics

United States Business Strategies BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window